v3.26.1
Note 6 - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2026
Mar. 31, 2025
Deferred tax assets:    
Capitalized research and development expense $ 1,275 $ 1,380
Net operating loss carryforwards 1,965 761
Accrual expenses and other current liabilities 4,677 3,438
Stock-based compensation 0 450
Total deferred tax assets 7,917 6,029
Less: valuation allowance (7,917) (5,723)
Net deferred tax assets 0 306
Deferred tax liabilities:    
Section 481A method change 0 (306)
Total deferred tax liabilities 0 (306)
Net deferred tax assets $ 0 $ 0